1 12, 2021 Maria Letizia Lai., Thyroid cancer in Sardinian pediatric patients: report of 63 cases and a review of the literature adlitterio663392021-12-01T14:58:32+01:00 Mehr erfahren
25 08, 2021 Valentina Guarnieri et. al., PIK3CA Mutation in the ShortHER Randomized Adjuvant Trial for Patients with Early HER2+ Breast Cancer: Association with Prognosis and Integration with PAM50 Subtype. Diatech Pharmacogenetics2021-08-25T12:02:27+02:00 Mehr erfahren
22 07, 2021 Pamela Trillo Aliaga et al., Should temozolomide be used on the basis of O6-methylguanine DNA methyltransferase status in patients with advanced neuroendocrine tumors? A systematic review and meta-analysis. adlitterio663392022-10-21T09:25:42+02:00 Mehr erfahren
24 06, 2021 Serena Ammendola et al., H3K27me3 immunostaining is diagnostic and prognostic in diffuse gliomas with oligodendroglial or mixed oligoastrocytic morphology adlitterio663392022-10-21T13:52:43+02:00 Mehr erfahren
15 06, 2021 Debora Olioso et al., Serum Exosomal microRNA-21, 222 and 124-3p as Noninvasive Predictive Biomarkers in Newly Diagnosed High-Grade Gliomas: A Prospective Study adlitterio663392022-10-21T14:02:53+02:00 Mehr erfahren
10 05, 2021 Enrico Berrino et al., High BRAF variant allele frequencies are associated with distinct pathological features and responsiveness to target therapy in melanoma patients. adlitterio663392022-10-21T14:12:17+02:00 Mehr erfahren
17 04, 2021 Yoon Ah Cho et al., Incidence, clinicopathologic, and genetic characteristics of mismatch repair gene-mutated glioblastomas adlitterio663392022-10-21T15:40:43+02:00 Mehr erfahren
18 01, 2021 Sara Ravaioli et al., An initiative to assess the quality of Tanzanian cervical cancer specimens for HPV and telomerase detection adlitterio663392022-10-21T16:10:17+02:00 Mehr erfahren
14 10, 2020 Federica Bertolini et. al., Second Primary Tumors in head and neck cancer patients: the importance of a “tailored” surveillance Diatech Pharmacogenetics2020-11-03T11:53:39+01:00 Mehr erfahren
4 09, 2020 Pierina Navarria et. al., Is IDH status the only factor predicting prognosis in newly diagnosed anaplastic glioma patients? Outcome evaluation and prognostic factor analysis in a single-institution large series Diatech Pharmacogenetics2020-09-04T13:57:59+02:00 Mehr erfahren
